Claus Olesen

Claus Olesen

Auto-generated profile, based on publicly available information

Claus Olesen

NMD Pharma A/S, Palle Juul-Jensens Boulevard 82, 8200 Aarhus N, Denmark

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2007 in Nature
Verified
Journal Article
Closed access
COClaus Olesen
Claus Olesen
MPMartin Picard
Martin Picard
AWAnne-Marie Lund Winther
Anne-Marie Lund Winther
CGClaus Gyrup
Claus Gyrup
JMJ. Preben Morth
J. Preben Morth
PNPoul Nissen
Poul Nissen

1 September 2010 in Quarterly Reviews of Biophysics
Verified
Journal Article
Closed access
PDF file
JMJesper V. Møller
Jesper V. Møller
COClaus Olesen
Claus Olesen
AWAnne-Marie Lund Winther
Anne-Marie Lund Winther
PNPoul Nissen
Poul Nissen
The sarcoplasmic (SERCA 1a) Ca2+-ATPase is a membrane protein abundantly present in skeletal mucles where it functions as an indispensable component of the excitation–contraction coupling, being at the expense of ATP hydrolysis involved in Ca2+/H+exchange with a high thermodynamic efficiency across the sarcoplasmic reticulum membrane. The transporter serves as a prototype of a whole family of cation transporters, the P-type ATPases, which in addition to Ca2+transporting proteins count Na+, K+-ATPase and H+, K+-, proton- and heavy metal transporting ATPases as prominent members. The ability in recent years to produce and analyze at atomic (2·3–3 Å) resolution 3D-crystals of Ca2+-transport intermediates of SERCA 1a has meant a breakthrough in our understanding of the structural aspects of the transport mechanism. We describe here the detailed construction of the ATPase in terms of one membraneous and three cytosolic domains held together by a central core that mediates coupling between Ca2+-transport and ATP hydrolysis. During turnover, the pump is present in two different conformational states, E1 and E2, with a preference for the binding of Ca2+and H+, respectively. We discuss how phosphorylated and non-phosphorylated forms of these conformational states with cytosolic, occluded or luminally exposed cation-binding sites are able to convert the chemical energy derived from ATP hydrolysis into an electrochemical gradient of Ca2+across the sarcoplasmic reticulum membrane. In conjunction with these basic reactions which serve as a structural framework for the transport function of other P-type ATPases as well, we also review the role of the lipid phase and the regulatory and thermodynamic aspects of the transport mechanism.

24 December 2004 in Science
Verified
Journal Article
Closed access
PDF file
COClaus Olesen
Claus Olesen
TSThomas Lykke-Møller Sørensen
Thomas Lykke-Møller Sørensen
RNRikke Christina Nielsen
Rikke Christina Nielsen
JMJesper Vuust Møller
Jesper Vuust Møller
PNPoul Nissen
Poul Nissen
P-type ATPases extract energy by hydrolysis of adenosine triphosphate (ATP) in two steps, formation and breakdown of a covalent phosphoenzyme intermediate. This process drives active transport and countertransport of the cation pumps. We have determined the crystal structure of rabbit sarcoplasmic reticulum Ca 2+ adenosine triphosphatase in complex with aluminum fluoride, which mimics the transition state of hydrolysis of the counterion-bound (protonated) phosphoenzyme. On the basis of structural analysis and biochemical data, we find this form to represent an occluded state of the proton counterions. Hydrolysis is catalyzed by the conserved Thr-Gly-Glu-Ser motif, and it exploits an associative nucleophilic reaction mechanism of the same type as phosphoryl transfer from ATP. On this basis, we propose a general mechanism of occluded transition states of Ca 2+ transport and H + countertransport coupled to phosphorylation and dephosphorylation, respectively.

1 December 2017 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
PSPankaj Sehgal
Pankaj Sehgal
PSPaula Szalai
Paula Szalai
COClaus Olesen
Claus Olesen
HPHelle Praetorius
Helle Praetorius
PNPoul Nissen
Poul Nissen
JMJesper V. Møller
Jesper V. Møller
Calcium (Ca2+) is a fundamental regulator of cell signaling and function. Thapsigargin (Tg) blocks the sarco/endoplasmic reticulum (ER) Ca2+-ATPase (SERCA), disrupts Ca2+ homeostasis, and causes cell death. However, the exact mechanisms whereby SERCA inhibition induces cell death are incompletely understood. Here, we report that low (0.1 μm) concentrations of Tg and Tg analogs with various long-chain substitutions at the O-8 position extensively inhibit SERCA1a-mediated Ca2+ transport. We also found that, in both prostate and breast cancer cells, exposure to Tg or Tg analogs for 1 day caused extensive drainage of the ER Ca2+ stores. This Ca2+ depletion was followed by markedly reduced cell proliferation rates and morphological changes that developed over 2–4 days and culminated in cell death. Interestingly, these changes were not accompanied by bulk increases in cytosolic Ca2+ levels. Moreover, knockdown of two key store-operated Ca2+ entry (SOCE) components, Orai1 and STIM1, did not reduce Tg cytotoxicity, indicating that SOCE and Ca2+ entry are not critical for Tg-induced cell death. However, we observed a correlation between the abilities of Tg and Tg analogs to deplete ER Ca2+ stores and their detrimental effects on cell viability. Furthermore, caspase activation and cell death were associated with a sustained unfolded protein response. We conclude that ER Ca2+ drainage and sustained unfolded protein response activation are key for initiation of apoptosis at low concentrations of Tg and Tg analogs, whereas high cytosolic Ca2+ levels and SOCE are not required.

27 June 2012 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
SDSamuel R. Denmeade
Samuel R. Denmeade
AMAnnastasiah M. Mhaka
Annastasiah M. Mhaka
DRD. Marc Rosen
D. Marc Rosen
WBW. Nathaniel Brennen
W. Nathaniel Brennen
SDSusan Dalrymple
Susan Dalrymple
JIJohn Isaacs
John Isaacs
A prostate-specific membrane antigen–activated prodrug selectively kills cancer cells and is being tested in patients with advanced cancer.

18 May 2006 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
AWAnne-Marie Lund Winther
Anne-Marie Lund Winther
TSThomas Lykke‐Møller Sørensen
Thomas Lykke‐Møller Sørensen
COClaus Olesen
Claus Olesen
JMJesper Vuust Møller
Jesper Vuust Møller
PNPoul Nissen
Poul Nissen
We present crystal structures of the calcium‐free E2 state of the sarcoplasmic reticulum Ca2+‐ATPase, stabilized by the inhibitor thapsigargin and the ATP analog AMPPCP. The structures allow us to describe the ATP binding site in a modulatory mode uncoupled from the Asp351 phosphorylation site. The Glu439 side chain interacts with AMPPCP via an Mg2+ ion in accordance with previous Fe2+‐cleavage studies implicating this residue in the ATPase cycle and in magnesium binding. Functional data on Ca2+ mediated activation indicate that the crystallized state represents an initial stage of ATP modulated deprotonation of E2, preceding the binding of Ca2+ ions in the membrane from the cytoplasmic side. We propose a mechanism of Ca2+ activation of phosphorylation leading directly from the compact E2‐ATP form to the Ca2E1‐ATP state. In addition, a role of Glu439 in ATP modulation of other steps of the functional cycle is suggested.